We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Ablynx Announces Extension of Nanobody Drug Discovery and Development Alliance

News   Dec 12, 2007

 
Ablynx Announces Extension of Nanobody Drug Discovery and Development Alliance
 
 
 

RELATED ARTICLES

Identifying Alzheimer's Drug Candidates with Anti-aging Properties

News

Old age is the greatest risk factor for many diseases, including Alzheimer's disease (AD) and cancer. Geroprotectors are a recently identified class of anti-aging compounds. New research has now identified a unique subclass of these compounds, dubbed geroneuroprotectors (GNPs), which are AD drug candidates and slow the aging process in mice.

READ MORE


Potential Path for Countering Oxidative Stress in a Range of Diseases

News

Scientists at Scripps Research have made a surprising discovery in their mission to understand how cells stay healthy, uncovering an important connection between a cell’s sugar metabolism and its antioxidant response.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Applied Sciences

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE